Tryp Therapeutics Stock Market Capitalization

Tryp Therapeutics fundamentals help investors to digest information that contributes to Tryp Therapeutics' financial success or failures. It also enables traders to predict the movement of Tryp OTC Stock. The fundamental analysis module provides a way to measure Tryp Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tryp Therapeutics otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tryp Therapeutics OTC Stock Market Capitalization Analysis

Tryp Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

 = 

Shares Outstanding

X

Share Price

More About Market Capitalization | All Equity Analysis

Current Tryp Therapeutics Market Capitalization

    
  6.56 M  
Most of Tryp Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tryp Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition

Based on the recorded statements, the market capitalization of Tryp Therapeutics is about 6.56 M. This is 99.95% lower than that of the Healthcare sector and 99.86% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 99.97% higher than that of the company.

Tryp Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tryp Therapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tryp Therapeutics could also be used in its relative valuation, which is a method of valuing Tryp Therapeutics by comparing valuation metrics of similar companies.
Tryp Therapeutics is currently under evaluation in market capitalization category among its peers.

Tryp Fundamentals

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Tryp OTC Stock

If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamental Analysis
View fundamental data based on most recent published financial statements